АкушерствоАнатомияАнестезиологияВакцинопрофилактикаВалеологияВетеринарияГигиенаЗаболеванияИммунологияКардиологияНеврологияНефрологияОнкологияОториноларингологияОфтальмологияПаразитологияПедиатрияПервая помощьПсихиатрияПульмонологияРеанимацияРевматологияСтоматологияТерапияТоксикологияТравматологияУрологияФармакологияФармацевтикаФизиотерапияФтизиатрияХирургияЭндокринологияЭпидемиология

Модифицированная шкала Рэнкина

Прочитайте:
  1. VI шкала «Загальна оцінка адаптованості дитини»
  2. VI шкала «Ставлення до вчителя»
  3. Вимірна шкала для визначення вмісту метилметакрилату
  4. Гейдельбергская шкала структурных изменений
  5. Досліджень, на основі яких базується Протокол (шкала рівнів доказовості)
  6. Количественная оценка тяжести повреждений по наиболее часто применяемым шкалам
  7. Количественная шкала стрессов
  8. Модифицированная операция Maze с использованием различных способов аблации (Maze IV)
  9. Оцінка фізичного розвитку школярів (шкала регресії за ростом)
Баллы Описание
  Симптоматика отсутствует
  Симптоматика не вызывает явного нарушения функций, пациент может выполнять любые повседневные действия
  Лёгкое нарушение функций, не способен выполнять повседневные действия в прежнем объёме, однако самостоятельно ухаживает за собой; посторонняя помощь не нужна
  Умеренное нарушение функций, нуждается в некоторой посторонней помощи, но может самостоятельно ходить
  Выраженное нарушение функций, не может без посторонней помощи ходить, ухаживать за собой
  Грубое нарушение функций, «прикован к постели», нарушение функций тазовых органов, нуждается в постоянном уходе и присмотре
  Летальный исход

Индекс Бартелла*

Приём пищи 0 — невозможен без посторонней помощи 5 — нужна некоторая помощь (при разрезании пищи, намазывании масла на хлеб и т.д.) либо нуждается в специальной диете 10 — самостоятельно
Приём ванны 0 — посторонняя помощь нужна 5 — посторонняя помощь не нужна
Личная гигиена 0 — нуждается в посторонней помощи 5 — самостоятельно моет лицо, причёсывается, чистит зубы, бреется
Одевание 0 — невозможно без посторонней помощи 5 — нужна посторонняя помощь, но приблизительно половину манипуляций выполняет самостоятельно 10 — самостоятельное (в том числе сам застёгивает пуговицы, молнии, завязывает шнурки)
Контроль функций прямой кишки 0 — недержание либо для опорожнения необходимы очистительные клизмы 5 — периодические нарушения 10 — полный контроль
Контроль функций мочевого пузыря 0 — недержание либо необходим катетер, пользоваться которым самостоятельно не может 5 — периодические нарушения 10 — полный контроль
Пользование унитазом 0 — невозможно без посторонней помощи 5 — нужна посторонняя помощь, но некоторые манипуляции может выполнять сам 10 — самостоятельно
Перемещение (с кровати на кресло и наоборот) 0 — невозможно, не может сидеть 5 — необходима помощь, сидеть может 10 — необходима незначительная помощь (физическая или вербальная) 15 — свободное
Перемещение (на ровной поверхности) 0 — невозможно или менее 40 м 5 — возможно с помощью инвалидного кресла (в том числе повороты), более 40 м 10 — может пройти с посторонней помощью (физической или вербальной) более 40 м 15 — самостоятельное (допустимо использование трости), более 40 м
Перемещение по ступенькам 0 — невозможно 5 — необходима помощь (физическая, вербальная) 10 — самостоятельное
     

* Оценка от 0 (полная инвалидизация) до 100 баллов (независимость от посторонней помощи).

 

Список литературы

1. Гусев Е.И.. Chwpw.Md В.И., ('тихонейаи Л.В., Кшшковский В.В., Айринн Н.Ю. '-Эпидемиология инсульт к I'осе и я,7 Consilium Medicum. —2003. - 5(5).

2. Boniia R. Epidemiology of sliokc // Lancet. -!l)02 - Vol. 33r». --;F. 342-344.

3. Boniia R.. Bcagkhole R., Asplwid A. // Currotn Opin Vuiro!. - 1494. -JVol. 7. - P. 5—10.

? 4. European Stroke Initiative Recommendations. 2004.// hitp-./www |.j eusi-siroke.org.

5. Williams G.R., Jiang J.G., Muichar D.B., Samsa G.P. incidence,'ind ot- % currence of total (first-ever and recurrent) stroke // Stroke. - 1949. -- Vol. 30 (12). - P. 2523-2528.6. Anderson C.S., Jamrozik K.D., Broadhurst R.J. etal. Predicting survival for 1 year among different subtypes of stroke: results from the Perth Community Stroke Study. — Stroke. — 1994. - Vol. 25. — P. 1935-1944.

7. Sacco R.L., Shi Т., Zamanillo M.C. et al. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study // Neuroloay. — 1994 — Vol 44 — P. 626-634.

8. Bamford. /., Sandercock P., Dennis M. etal. Classification and natural history of clinically identifiable subtypes of cerebral infarction /,/ lancet — 1991. - Vol. 337. - P. 1521-1526.

9. Asplund K.. Marke I..A.. TeremA.. Gustafsson С Wester P. Costs and gains in stroke prevention: curopean perspective // Cerebrosxasc. Dis. — 1993 -Vol. 3 (suppl). - P. 34- 42.

10. Kaste M.. Fogelholm R. Economic burden of stroke and the evaluation of new therapies // A. Pub!. Hltli. — 1998. — Vol. 112. — P. 103-112.

11. Stegmayr В.. Vinogradava Т., Malyutina S., Peltonen A/., Nikitin Y.. Asplund K. Widening gap of stroke between east and west: eightyear trends in occurrence and risk factors in Russia and Sweden // Stroke. —?()()() — Vol 31 — P. 2-8.

12. Tlwrvaldsen P., Davidsen M.. Bronnum-llansen H.. Schroll M. Stable stroke occurrence despite incidence reduction in an aging population: stroke trends in the Danish monitoring trends and determinants in cardiovascular disease (MONICA) population // Stroke. — 1999. - Vol. 10. — P. 2529-2534.

13. Tlwrvaldsen P.. Kuulasmaa A'., Rajakangas A.M., Rastenyte I).. Sarti C, Wilhelmsen L. Stroke trends in the WHO MONICA project // Stroke. -1997. - Vol. 28. - P. 500-506.

14. James C. Grotta. PIER. Clinical guidance from ACT. Stroke and transient ischemic attack.

15. Cirau A.J., Buggle /"., Heindl S. el al. Recent infection as a risk factor for cerebrovascular ischemia /7 Stroke. — 1995. — Vol. 26. — P. 373-379.

16. I so H., Jacobs D.R., Wentworth D. et al. Serum cholesterol levels and six-year mortality from stroke in 350.977 men screened for the multiple risk factor intervention trial // N. Engl. J. Med. - 1989. — Vol. 320. -P. 904-910.

17. Hankey G.J., SlatteryJ.M., Warlow С P. Prognosis and prognostic factors of retinal infarction: a prospective cohort study // Br. J. Mcd. — 1991. -Vol. 302. - P. 499-504.

18. Mead G.E., WardlawJ.M., Lewis S.C. etal. Can simple clinical features be used to identify patients with severe carotid stenosis on Doppler ultrasound? // J. Neurol. Neurosurg. Psychiatry. — 1999. — Vol. 66. - P. 16-19.

19. F.ndarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study // JAMA. — 1995. — Vol. 273. - P. 1421-1428.

20. Helgason СМ., Wolf P.A. American Heart Association Prevention Conference IV: prevention and rehabilitation of stroke: executive summary// Circulation. - 1997. - Vol. 96. -- P. 701-707.

21. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study // Arch. Intern. Med. — 1987. - Vol. 147. - P. 1561-1564.

22. llannaford P.C., Croft P.R., Kay C.R. et al. Oral contraceptives and stroke: Evidence from the Royal College of General Practitioners" Oral Contraception Study // Stroke. - 1994. - Vol. 25. - P. 935-942.

23. Wassenheil-SmollerS.. HendrixS.L., Limacher A/., HeissG., KooperbergC, Baird A. et al. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial //JAMA. — 2003. — Vol. 2H9. - P. 2673-2684.

24. Everson S.A., Roberts R.L., Goldberg D.F.. et al. Depressive symptoms and increased risk of stroke mortality over a 29-year period // Arch. Intern. Med. - 1998. - Vol. 158. - P. I 133-1138.

25. Petty G.W.. Klumdheria B.K.. Whisnant J.P. etal. Predictors of cerebrovascular events and death among patients with valvular heart disease: a population-based study// Stroke. - 2000. - Vol. 31. — P. 2628-2635.

26. Oremia A.J.. Petty G.W., Khandheria B.K. ei al Risk of stroke with mitral valve prolapse in populaiion-baed cohort study // Stroke. — 1995. -Vol. 26. - P. 7-13.

27. I he Stroke Prevention in Airial Fibrillation Investigators: Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients al risk,// Ann. Intern. Med. - 1992. - Vol. 116 (I). - P. I 5.

28. MaeMahon S., Rodgers A. Blood pressure, antihypertensive treatment and stroke risk/,/J. Hyperions Suppl. - 1994. - Vol.'l2 (10). - P. 5 14.

29. Balkan В., Shipley A/.. Jarrett R.J.. Pyoivla A'.. Pyorala A/.. Foiiian A. etui High blood glucose concentration is a risk factor for mortality in middle-aged nondiabctic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study // Diabetes Care. — 1998. - Vol. 21."- P. 360-367.

30. Bucher II.C. Griffith L.E.. Guyutt G.H. Effect of HMGcoA reduclase inhibitors on stroke. A meta-analysis of randomized, controlled trials // Ann. Intern. Med. — 1998. - Vol. 128. - P. 89-95.

31. Sever P.S., DahlofB., PoulterN.R. et al. Prevention of coronary and stroke events with alorvastatin in hypertensive patients who have average or lower-than-avcrage cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a rnulticcntre randomised controlled trial.// Lancet. - 2003. - Vol. 361 (9364). - P. 1149-1158.

32. Collins R., Armitage J., Parish S. el al. Effects of cholesterol-lowering I/with simvastatin on stroke and other major vascular events in 20536 people Tfwith cerebrovascular disease or other high-risk conditions // Lancet. — 2004. — IVol. 363 (9411). - P. 757-767. л 33. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) // Lancet. — 1994. - Vol. 344. - P. 1383-1389.

34. WolfP.A., D'Agostino R.B.. Kannel W.B., Bonita R., BelangerAJ. Cigarette smoking as a risk factor for stroke. The Framingham Study // JAMA. — 1988. - Vol. 259. - P. 1025-1029.

35. Colditz G.A., Bonita R., Stampfer M.J., Willett W.C., Rosner B,, Speizer F.E., Hennekens СИ. Cigarette smoking and risk of stroke in middle-aged women II N. Engl. J. Med. - I98S. - Vol. 318. - P. 937-941.

36. Reynolds K., Lewis L.B., Nolen J.D.L., Kinney G.L., Sathya В., He J. Alcohol consumption and risk ol'stroke. A meta-analysis,//JAMA. — 2003. — Vol. 2S9. - P. 579-588.

37. YusujS., Sleight P.. Pogue J., Bosch J., Davies R., Dagenais G. EITecis of an angiotensin-converting-eiuyme inhibitor, nmiipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators //' N. Engl. J. Med. - 2000. - Vol. 342. - P. 145-153.

38. Progress Collaborative Group. Randomised trial of a pcrindopril-bascd blood-pressure-lowering regimen among 6.105 individuals with previous stroke or transient, ischaemic attack /,/ Lancet. — 2001. — Vol. 358. ---P. 1033-1041.

39. Koudsraal P. Anticoagulants for presenting siroke in patients wish nonrheuinalic atrial lihrillation and a history of stroke or transient ischeinic attacks f/ "1 he Cochrane Librarv. Issue 3. — O.xfoid: Update Software. 1999.

40. Risk factors for siroke and efficacy ofantithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomi/ed contiolled trials // Arch. Inlern. Med. - 1994. - Vol. 154. - P. 1449-1457.

41. Hurt R.G., Pearce LA.. Me Bride R., Rothbart R.M.. Asinger R.W. Factors associated with ischemic stroke during aspirin therapy in alrial fibrillation: analysis of 2012 participants in the SPAF l-lll clinical trials. The Siroke Prevention in Atrial Fibrillation (SPAF) Investigators /7 Stroke. — 1999. — Vol. 30. - P. 1223-1229.

42. Adams H.P. Jr., Bendixen B.H.. Kappelle L.J., Biller. /.. Love B.B., Gordon D.L., Marsh E.E. 3rd. Classification of subtype of acute ischemic siroke. Definitions for use in a muKicentei clinic.ii trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment // Siroke. - 1993. - Vol. 24 (I). - P. 35-41.

43. Brott Т.. Adams H.P. Jr., Olinger C.P. et al. Measurements of acute cerebral infarction: a clinical examination scale II Stroke. — 1989. — Vol. 20. — P. 864-870.

44. Goldstein L.B., Benels C, Davis J.N. Interrater reliability of the NIH stroke scale // Arch. Neurol. - 1989. - Vol. 46. - P. 660-662.

45. Muir K. W., Weir C.J., Murray G.D.. Povey C, Lees K.R. Comparison of neurological scales and scoring systems for acute stroke prognosis // Stroke. — 1996. - Vol. 27. - P. 1817-1820.

46. Adams H.P. Jr., Davis P.H., Leira E.G. etal. Baseline NIH Stroke Scale score strongly predicts outcome after stroke // Neurology. — 1999. — Vol. 53. — P. 126-131.

47. Kwiatkowski T.G.. Libman R.B., Frankel M., Til/ey B.C., Morgenstern L.B.. Lu M. Effects of tissue plasminogen activator for acute ischemic stroke at one year: National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group//N. Engl. J. Med. — 1999. — Vol. 340. - P. 1781-1787.

48. The MNDSx-VX Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke // Stroke. — 1997. — Vol. 28. — P. 2109-2118.

49. Arhoix A., Comes £'.. Massons J. et al. Relevance of early seizures for in-hospita! mortality in acute cerebrovascular disease // Neurology. — 1996 — Vol. 47. - P. 1429-1435.

50. Mann G, Hankey G.J.. Cameron D. Swallowing function after stroke: Prognosis and prognostic factors at 6 months/.'Stroke. - I(W. Vol. 3U. p. 744-74X.

51. Barer D.H. The natural history and functional consequences оГау~рЬ.а;.на after hemispheric stroke /Л1. Neurol. Neurosunz. Psychiatry. - 19K9 - Vol. 52. --P. 236-241.

52. Prctvott R.J., Garnnvay W.M.. Akhwr Л J. Predicting functioua! outcome following acute stroke using a standard clinical examination //' Stroke. — 1 Он? -Vol. 13 Ъ.). - P. 641-647.

53. Anderson C.S.. Jamrozik K.D.. Bmadhum R.J. et a!. Predict ing survival lor I year among different subtypes uf stroke: Results from the Perth Communitv Stroke Study//' Stroke. - "lW. - Vol. 25. - P. 1935-1944.

54. Panzer RJ., leihel J.H., Barker W.H., Griner /'./-'. Predicting the likelihood of hemorrhage in patients with siroke/'Arch. Intern Med. — 1485. — Vol. 145. - P i 800-1803.

55. Duvaios A., Cendrci /:., Teruel J. el al. Deitrioraiing ischeinic stroke: Risk factors and prognosis // Ncurologv - 1990. — Vol. 40. - P. 1865-1869.

56. Koudstaal P.J., van Gijn. /., Klootwijk A.P.J. a al. Holier monilorMg in patients with transient and focal ischaemic attacks of the brain /7 Siroke — I9S6. - Vol. 17 (2). - P. 192-195.

57. Blakeley D.D., Oddone E.Z.. Hasselblad V. etal. Noninvasive carotid artery testing: a meia-analylic review //Ann. Intern. Med. — 1995. — Vol. 122. - P. 360-367.

58. Mini R.L., Broderkk M., Carpenter J. P. etal. Blinded-reader comparison of magnetic resonance angiography and duplex ultrasonography for carotid artery bifurcation stenosis // Stroke. — 1994. — Vol. 25. — P. 4—10.

59. Collaborative systematic review of the randomised trials of organised inpatient (siroke unit) care after stroke. Stroke Unit Trialists' Collaboration // BMJ. - 1997. -Vol. 314. - P. 1151-1159.60. Indredavik В., Вакке F., Slordahl S.A., Rokseth R., Haheim L.L. Treatment in a combined acute and rehabilitation stroke unit: which aspects are most important? // Stroke. — 1999. — Vol. 30. — P. 917-923.

61. Stroke Unit Trialists' Collaboration. Organised inpatienl (stroke unit) care for stroke,// Cochrane Database Syst. Rev. — 2002. - (1):CD000197.

62. Evans A.. Harraf F., Donaldson N., Kalra L. Randomized controlled study of stroke unit care versus stroke team care in different stroke subtypes // Stroke. — 2002. -™ Vol. 33 — P. 449-455.

63. Sulch /A, Melhoum A.. Perez /.. Kalra L. Integrated care pathways and quality of life on a stroke rehabilitation unit /7 Stroke. — 2002. — Vol. 3.3. — P. i 600-1604.

64. Schroder J., Luders S., Kulschewski A., Renter J., Zidek W., Treib J. etui. The ACCESS Study: evaluation of" Acute Candesartaa Cilexetil Therap\ in Stroke Survivors// Stroke. - 2003 - Vol. 34. — P. 1699-1703.

65. Gordon C, Hewer K.I... \\'ade 1). 7". Dysphagia in acute stroke.// BYIJ. — 1987 - Vol. 295. - P. 411-414.

66. Peniilgton G.R.. Krutsch 1.4. Swallowing disorders: assessment and rehabilitation /7 Brit. J. Mosp..Vied. - 1940. -•" Vol. 44. - P. J7-22.

67. Linden P.. Siebens -Ы. Dysphagia: prediclin.n larvngeal penetration // Arch,. Phys. Med. Rehabsl - 1983. -Voi. d4. - P. 2SI--2H4.

6S. Homer.!., Вгачт S.R.. Mawey LAV. Aspiration in bilateral stroke pa-lieniv » validation stud)- // Wmoiogy. - 1993. - Vol. 43. — P. 430-433.

69. Par/. ('.. Neil! P.A. Management of neurological dysphajiui // <_" 1 ir; H.-iwh. - 1994. - Vol. S - P. Тбб-174.

70. Smithard D.G.. (.'irxkfiird С'. D\splmgia: Are speech and language therapists coping with increasing referrals? // CSLT Bulletin. - 1995. - March 8-9.

7i Яворская В.A. Ф.юмин Ю.В., Льотг II.В., Тревгнюк А.В. Тромоо.ш-тичеекая герапия: становление и соиреченн.ы практика ннутриненною тромоо-'чгзиса при остром ишемическом инсульте // Инсулм. Приложение к жури. неьр. и нси\. — 2005. — X? 15. — С. 13-2".

72. Mahoncy I'.!., Ikmh.d D. Functional evaluation: the Rarthel Index /,' Maryland State Med. J. - 1965 - Vol. 14. — P. 56-61.

73. Bamford J, Sand^nocL P.. Dennis M. el a/. Classification and natural history of clinical sub types of cerebral infarction //' Lancet. — 1991. — Vol. 337. - P. i521-1526.

74. Adams II., Adams R.. Zop/ю G, Goldstein L.B. Guidelines for the Early Management of Patients With Ischemic Stroke // Stroke. — 2005. - Vol. 36. - P. 916.

75. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6.105 individuals with previous stroke or transient ischaetnic attack // Lancet. — 200!. — Sep. 29. — Vol. 358 (9287). - P. 1033-1041.

76. Harker L.A., Boissel J.P., Pilgrim A.J., Gent M. Comparative safety and tolcrabilily of clopidogrel and aspirin: results from CAPRIE. CAPRIE Steering

Committee and Investigators. Clopidogrel versus aspirin in patients at risk of ischaemic events // Drug Saf. - 1999. - Oct. 21 (4). - P. 325-335.

77. Coull B.M., Williams L.S., Goldstein L.B., MeschiaJ.F. et al. Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke // Stroke. — 2002. — Vol. 33. - P. 1934.

78. Garrett V.E., Scott J.A., Coslich J., Aubrey D.L., Gross J. Bladder emptying assessment in stroke patients // Arch. Phys. Mcd. Rehabil. — 1989. — Vol. 70.-P. 41-43.

79. The Internationa! Stroke Trial (1ST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group /,/ Lancet. -1997. - Vol. 349. - P. 1569-1581.

80. Bergc /., Sandcnock P. Aniicoagulants versus antipiatelet agents for acute ischaemic stroke // Cochrane Database Syst Rev. - 2002. - CD003242.

81. Turpie A.G.. Hirsh J.. Gent M., Julian I)., Johnson. /. Prevention of deep vein thrombosis in potential neiirosurgical patients. A randomised trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control /, Arch, intern. Vied. -- 1989. - Vol. 149. - P. 679-6SI.

82. Brandsiater M.E.. Roth t'.J.. Siebens //.(.'. Venous ihromhoembohMTi m stroke: literature review and implications lor clinical practice /./ Arch. Pins. Med. Rehabil. -- 1992. - Vol. 73. - P. -79-391.

H3. Silver F.L., Sam's J.W., Lewi* A.J., Hachlnsk: V C. Larly mortality

following stroke. A prospective review.,'/ Stroke...... 195*4. — Vol. tb —

P. 492 -496.

84. Warlow C. Ogsron I).. Douglas A S. Deep venous ihrombo.sis of the kg-, after stroke. Incidence and predisposing factors // BM.I. — 1976. — Vo! I. — P. 117K-1181.

85. Tissue plasminogen activator for acute isehemic stroke. The National Institute of Neurological Disorders and Stroke п-РЛ Stroke Study Group // N. Hngl. J Med. - 1995. - Vol. 3U - p. 1581-1587.

86. Haley E.C.Jr.. I ewandowski C, Tilley И.С. Myths regarding the NINDS rt-PA Stroke Trial: setting the record straight | Editorial| // Ann. Umerg. Med. — 1997. — Vol. 30. - P. 676-682.

87. Marler J.R.. Jones P.W., Emr M. Setting New Directions for Stroke Care: Proceedings of a National Symposium on Rapid Identification and Treatment ot Acute Stroke. — National Institute of Neurological Disorders and Stroke. U.S. Office of Scientific and Health Reports. Bethesda, MD: National institute of Neurological Disorders and Stroke, National Institutes of Health, 1997. - N1H publication no. 97-4239.

88. Adams H.P. Jr, Brott T.G., Fur/an A.J., Gomez C.R., GrotsaJ.. Helgason CM. et al. Guidelines for thrombolylic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement ibr healthcare professionals from a Special Writing Group of the StrokeCouncil. American Heart Association // Circulation. — 1996. — Vol. 94. — P. 1167-1174.

89. del Zoppo G.J., Higashida R.T., Furian A.J., Pessin M.S., Rowley H.A., Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism // Stroke. — 1998. — Vol. 29. - l\ 4-11.

90. Lisboa R.C.. Jovamn-ic B.D.. Alberts M.J. Analysis of the safety and efllcacy of mlra-arterial ihrombolytic therapy in ischemic stroke // Stroke. — 2002. - Vol. 33. - P, 2866-2H7L

91. Karolintka stroke update /7 Update on stroke therapy. — 2004.

92. Randomised сом.ю\'кй trial of streptokinase, aspirin, and combination of hoih in treatment of acute iscliaemic stroke. Multicentre Acute Stroke Trial-Itah (V1AST-I) Group /,' Lancet, - 1995. - Vol. 346. - I'. 1509-1514.

93. Ttirombolytic therapy with strepiokinase in acme ischemic stroke. The Muliicenter Acute Stroke Trial-Europe Stud\ (iroup /,/ N. flnjil. J. Med. --!W6 - Vol. 33л. - P. 145-150.

94. Donnan G.A., DavisS.M., Chambers R.R. Gates F.C. Нсшкеу G.J. McheilJ J. ei al. Frialsofstreptokinase in seve/e acute ischaemic stroke ji.etterj // lancet. —1995. - Vol. 345. - P 578-579.

95. CAS'J: randomised placebo-conl rolled trial of early aspirin use in 20,000 patients with :icuie isc'naemlc stroke. CAS"! (Chinese Acute Stroke Trial) Collaborative Group// Lancet. - 1997. - Vol. 349. - P. 1641-1649

96. Low molecular weight hepjrinoid. ORG 10172 (danaparoid). and outcome after acute ischemic stroke: a randomized controlled trial The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators //.1.ЛМЛ. - 1998. — Vol. 279. — P. 1265-1272.

97. Alters С И'. Hart R.G, Liasep H.L. Newell DAY., Saav R.I. AHA Scientific Statement. Supplement to the guideline!) for the management of transient ischemic attacks: a statement from the Ad Hoc Committee on Guidelines for ihe Management of Transient Ischemic Attacks, Stroke Council. American Heart Association // Stroke. — 1999. — Vol. 30 — P. 2502-2511.

98. Collaborative overview of randomised trials of antiplatelet therapy-1: Prevention of death, myocardkil infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelel Trialists Collaboration // BMJ.' '- 1994. - Vol. 308. - P. 81-106.

99. Amarenco P., Bogousslavsky J., Callahun A. et al. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators // N. Engl. j. Med. - 2006. - Vol. 355 (6). - P. 549-559

100. A randomised, blinded, trial of ciopidogrel versus aspirin in patients at risk of ischacmic events (CAPRIE). CAPRIE Steering Committee // Lancet. —1996. - Vol. 348. - P. 1329-1339.

101. Diener H.C., Cunha L., Forbes C, SiveniuxJ., Smets P., Lowenthal A. \ European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in I the secondary prevention of stroke // J. Ncurol. Sci. — 1996. — Vol. 143. —-! P. 1-13.

102. PlehnJ.F.. Davis B.R., Sacks F.M.. Rouleau J.L., PfefferM.A., Bernstein V. [ et al. Reduction of stroke incidence after myocardial infarction with pravastalin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators // I Circulation. - 1999. - Vol. 99. - P. 216-223.

103. Mohr J.P., Thompson J.L., lunar R.M., Levin В., Sacco R.L., Furie A.I. et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke // N. Engl. Vied. - 2001. - Vol. 345. - P. 1444--1451.

104. Brashear A., Gordon M.F., Elovic L.. Kassieieh V.D., Maniniak C, Do M. et al. Intramuscular injection of botulinum toxin for the treatment of wrist anil finger spasticity after a stroke /7 N. Lngl..!. Med. — 2002. — Vol. 347. - P. 395-400.

105. Sze F.K.. Wong E.. Or K.K., Lau J., Woo./. Does acupuncture improve motor recovery.ifter stroke? A meta-analy^is of randomized controlled trials /./ Stroke. - 2002. - Vol. 33. - P. 2ЫМ--2619.

106. Teasell R. W., Bach D.. McRrae M. Prevalence and recovery- of aspiration post stroke. A retrospective analysis // Dysphagia. — 1994. — Vol. 9. — P. 35-39.

107. Smithani D. G., Seill P. A, Parks C.. Morris J. Compl icai ions and outcome after acute stroke: does dysphainu matter? // Stroke. — 1996. - Vol. 27. — P. 1-5.

108. Park R.H., Allison M.C.. Lang.I., Spence L\. Morris A.J., Danesh B.J. ei al. Randomised comparison of percutaneous endo>.copic gaslrostomy and nasogasti'ic tube feeding in patients with persisting neurological dysphagia //' BMJ. - 1992. - Vol. 304, P. 1406-1409.

109. Norton В.. I lamer-Ward M.. Donnelly M.T.. Long R.G., Holmes G.K. A randomised prospective comparison of percutaneous endoscopic gastrostomy and nasogastric tube feeding alter acute dysphagic stroke // BMJ. — 1996. — Vol. 312. - P. 13-16.

110. Wanklyn P.. Cox N., Be/field P. Outcome in patients who require gastrostomy after a stroke // Age Ageing. — 1995. — Vol. 24. — P. 510-514.

111. Groher M.F.. Bolus management and aspiration: pneumonia in patients with pseudobulbar dysphagia // Dysphagia. — 1987. — Vol. 1. — P. 215-216.

112. Logemann J.A., Kahrilas P.J., Kobara M., Vakil N.B. The benefit of head rotation on pharyngoesophaizeal dysphagia // Arch. Phys. Vied. Rehabil. — 1989. -Vol. 70."- P. 767-771.

113. Lazfirus C.L., Logemann J.A., RademakerA.W., Kahrilas P.J., Pajak Т., Lazar R. et al. Effects of bolus volume, viscosity and repeated swallows in non stroke subjects and stroke patients /,/ Arch. Phys. Med. Rehabil. — 1993. — Vol. 74. - P. 1066-1070.114. Kahhlas P.J., Logemann J.A., Krugler С, Flanagan E. Volitional augmentation of upper oesophageal sphincter opening during swallow // Am. J. Physiol. - 1991. - Vol. 260. - P. 450-456.

115. Kahrilas P..I., Lagemann J.A. Volume accommodation during swallowing // Dysphagia. - 1993. - Vol. 8. - P. 259-265.

116. Martin B.J.. Lagemann J.A.. Shaker /?., Dodds W.J. Normal laryngeal valving patterns during three breath-hold manoeuvres: a pilot investigation // Dysphagia. - 1993. - Vol. 8. - P. 11-20.

117. Braus D.I'., Kniuss J.K., Sirohcl J. The shoulder hand syndrome after stroke: a prospective clinical trial // Ann. Ncurol. — 1994. — Vol. 36. — P. 728-733.

118. Chalsen G.G.. Fitzjuitriek K.A., Navia R.A., Bean S.A., Reding M.J. Prevalence of the shoulder-hand pain syndrome in an in-patient stroke rehabilitation population: a quantitative cross-sectioned study //' J. Neurol. Rehab. - 1987. - Vol. 1. - P. 137-141.

119. ForsterA. The painful hcmiplegic shoulder: physiotherapy treatment // Reviews m Clinical Gerontology...... 1994. — Vol. 4. — P. 343-348.

120. Partridge C.J.. Edwards S.M., Mee R., van Langenberghe II.V. Hemiplegic shoulder pain, a study of two methods of physiotherapy treatment /,/ Clin. Rekibil. - 1990. - Vol. 4. - P. 43-49.

121. Turner-Stokes I... Hassan N. Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part I: Diagnosis, frequency and impact // Clin. Rehabil. — 2002. - Vol. 16. — P. 231-247.

122. Turner-Stokes!.., Hassan,V. Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Pan 2: Treatment alternatives// Clin. Rehabil. - 2002. - Vol. 16. - P. 248-260.

121 Wade D.T.. Wood V.A., Hewer R.L. Recover,' after stroke: the first 3 months //.(. Neurol. Neurosurg. Psychiatry. — 19X5. — Vol. 48. — P. 7-13.

124. Smith M.E., Garraway W.M., Smith D.L., Akhtar A.J. Therapy impact on functional outcome in a controlled trial of stroke rehabilitation // Arch. Phys. Mod. Rehabil. - 1982. - Vol. 6.3....... P. 21-24.

125. Paolucci S.. Antunucci 0., Grassn M.G., Mvrelli D.. Truisi E., Cairo P. ct at. Post-stroke depression, antidepressunt treatment and rehabilitation results. A case-control study// Cerebrovasc. Dis. -?001. - Vol. 12. - P. 264-271.

126. Yamamoto II., Rogousslavsky.1., van Mellc G. Different predictors of neurological worsening in different causes of stroke//Arch. Ncurol. - 1998. — Vol. 55. - P. 481-483.

127. Qureshi A.L., Safdar K., Weil J. ei at. Predictors of early deterioration and mortality in black Americans with spontaneous intracerrebral hemorrhage // Stroke. - 1995. - Vol. 26. - P. 1764-1767.

128. BurnJ., Dennis M., BamfordJ. etal. Long-term risk of recurrent stroke after a first-ever stroke: the Oxfordshire community stroke project // Stroke. — 1994. - Vol. 25. - P. 333-337.

129. Prencipe M., Culasso F., Rasura Met at. Long-term prognosis after a minor stroke: 10-year mortality and major stroke recurrence rates in a hospital-based cohort // Stroke. — 1998. — Vol. 29. — P. 126-132.

130. Toni D., Fiorelli M., Bastianello S. et at. Acute ischaemic strokes improving during the first 48 hours of onset: predictability, outcome, and possible mechanism // Stroke. — 1997. — Vol. 28. — P. 10-14.

131. Lin H.J., Wolf P.A., Kelly-Hayes M. et at. Stroke severity in atrial fibrillation: The Framingham Study // Stroke. — 1996 — Vol 27 — P. 1760-1764.

132. The European Atrial Fibrillation Study Group. Optimal oral anticoagulation therapy with nonrhcumatic atrial fibrillation and recent cerebral ischemia // \. Eng. J. Med. - 1995. — Vol. 333. - P. 5-10.

133. Faster V., Ryden I.E.. Asinger R.W.. Cannom D.S. et at. ACC/AHA/ ESC guidelines for the management of patients with atrial fibrillation: executive summary//J. Am. Coll. Cardiol. — 2001. — Vol. 38. — P. 1231-1266.

134. Kamran S.I., Downey D., Ruff R.L. Pneumatic sequential compression reduces the risk of deep vein thrombosis in stroke patients // Neurology — 1998. - Vol. 50. - P. 1683-1688.

135. Hsia A.W., Sachdev H.S., Tomlinson J., Hamilton S.A., Tang D.C. F.flieacy of IV tissue plasminogen activator in acute stroke: does stroke subtype really matter? // Neurology. — 2003. — Vol. 61. — P. 71-75.

 

МИГРЕНЬ

Мигрень — заболевание, предположительно связанное с дисфункцией вазомоторной регуляции и проявляющееся приступами головной боли, обычно пульсирующего характера, часто сопровождающейся тошнотой, рвотой, фото- и фонофобией.

МКБ-10: G43 Мигрень; G43.0 Мигрень без ауры [простая мигрень]; G43.1 Мигрень с аурой [классическая мигрень]: аура без головной боли, базилярная, эквиваленты, семейная гемиплегическая, гемипле-гическая, с типичной аурой; G43.2 Мигренозный статус; G43.3 Осложнённая мигрень; G43.8 Другая мигрень: офтальмоплегическая*, ретинальная; G43.9 Мигрень неуточнённая.

Дата добавления: 2015-11-02 | Просмотры: 1368 | Нарушение авторских прав

При использовании материала ссылка на сайт medlec.org обязательна! (0.03 сек.)